← Browse by Condition
Medical Condition
prostatic neoplasms
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 3, Phase 1, Phase 2
NCT00923221
Recruiting
Collection of Blood From Patients With Prostate Cancer
Enrollment
1,000 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT02869594
Recruiting
Institut Paoli Calmettes Prostate Cancer Database
Enrollment
10,000 pts
Location
France
Sponsor
Institut Paoli-Calmettes
NCT06925737 Phase 3
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Enrollment
1,440 pts
Location
United States, Argen...
Sponsor
Merck Sharp & Dohme LLC
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Enrollment
1,314 pts
Location
United States, Austr...
Sponsor
Merck Sharp & Dohme LLC
NCT01834001
Recruiting
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT07319871 Phase 1
Recruiting
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
Enrollment
40 pts
Location
United States, Unite...
Sponsor
Janssen Research & Development...
NCT05616650 Phase 2
Recruiting
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
Enrollment
42 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT04833426 Phase 3
Recruiting
Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy
Enrollment
140 pts
Location
Netherlands
Sponsor
Canisius-Wilhelmina Hospital